Publications

2025

Advancements in minimally invasive interventional oncology procedures for painful sacral metastases under imaging guidanceJiang W, Gan D, Johnson M, Latich I, Lee F. Advancements in minimally invasive interventional oncology procedures for painful sacral metastases under imaging guidance. EngMedicine 2025, 2: 100051. DOI: 10.1016/j.engmed.2024.100051.
Deaths: Iatrogenic Deaths—PathologyGill J, Turbiville D. Deaths: Iatrogenic Deaths—Pathology. 2025, 90-95. DOI: 10.1016/b978-0-443-21441-7.00043-1.
Falls From Height; Physical Findings—AdultGill J, Clark C. Falls From Height; Physical Findings—Adult. 2025, 499-506. DOI: 10.1016/b978-0-443-21441-7.00080-7.
Autopsy: Infectious and Serious Communicable DiseasesGill J, Brooks E. Autopsy: Infectious and Serious Communicable Diseases. 2025, 455-467. DOI: 10.1016/b978-0-443-21441-7.00021-2.
6 Ichthyosiform Dermatoses ☆ ☆ This article is a revision of the previous edition article by Howard P. Baden and John J. DiGiovanna, © 2013, Elsevier Ltd.Echeandia-Francis C, Baden H, DiGiovanna J, Choate K. 6 Ichthyosiform Dermatoses ☆ ☆ This article is a revision of the previous edition article by Howard P. Baden and John J. DiGiovanna, © 2013, Elsevier Ltd. 2025, 209-243. DOI: 10.1016/b978-0-12-812531-1.00003-8.

2024

Hepatoprotective role of Pueraria tuberosa water extract (PTWE) in CCl4-induced liver injury through different signaling pathwaysPrerana Aditi, Vahab Ali, Mayank Choubey, Munichandra Babu Tirumalasetty, Harsh Pandey, Shivani Srivastava, Yamini Bhusan Tripathi. Hepatoprotective role of Pueraria tuberosa water extract (PTWE) in CCl4-induced liver injury through different signaling pathways. Advances in Traditional Medicine. 2024.
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasmsUhlig J, Nie J, Gibson J, Cecchini M, Stein S, Lacy J, Kunz P, Kim H. Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms. Scientific Reports 2024, 14: 30536. PMID: 39690170, PMCID: PMC11652651, DOI: 10.1038/s41598-024-81518-4.
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemiasHamdan H, Liu Y, Wang S, Bledsoe J, Chisholm K, Siddon A, Ohgami R, George T, Kurzer J, Hasserjian R, Arber D, Bagg A, Foucar K, Margolskee E, Laczko D, Chen W, Fuda F, Aggarwal N, Weinberg O. Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemias. EJHaem 2024 DOI: 10.1002/jha2.1052.
Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatmentDamsky W, King B. Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment. Clinics In Dermatology 2024 PMID: 39694198, DOI: 10.1016/j.clindermatol.2024.12.017.
Vascular Endothelial Cells Derived from Transgene-Free Pig Induced Pluripotent Stem Cells for Vascular Tissue EngineeringBatty L, Park J, Qin L, Riaz M, Lin Y, Xu Z, Gao X, Li X, Lopez C, Zhang W, Hoareau M, Fallon M, Huang Y, Luo H, Luo J, Ménoret S, Li P, Jiang Z, Smith P, Sachs D, Tellides G, Anegon I, Pober J, Liu P, Qyang Y. Vascular Endothelial Cells Derived from Transgene-Free Pig Induced Pluripotent Stem Cells for Vascular Tissue Engineering. Acta Biomaterialia 2024 PMID: 39681154, DOI: 10.1016/j.actbio.2024.12.033.
Medical Education in DermatologyImaeda S, Tomayko M. Medical Education in Dermatology. Clinics In Dermatology 2024 PMID: 39681292, DOI: 10.1016/j.clindermatol.2024.12.010.
Development of tetracycline analogues with increased aqueous stability for the treatment of mycobacterial infectionsLiu J, Phelps G, Dunn C, Murphy P, Wilt L, Loudon V, Lee R, Fernando D, Yang L, Tran K, Troyer B, Obregon-Henao A, Lee R. Development of tetracycline analogues with increased aqueous stability for the treatment of mycobacterial infections. Tuberculosis 2024, 150: 102592. PMID: 39708619, DOI: 10.1016/j.tube.2024.102592.
Exploring the Molecular Link Between Diabetes and Erectile Dysfunction Through Single-Cell Transcriptome Analysis.Begum M, Choubey M, Tirumalasetty MB, Arbee S, Sadik S, Mohib MM, Srivastava S, Minhaz N, Alam R, Mohiuddin MS. Exploring the Molecular Link Between Diabetes and Erectile Dysfunction Through Single-Cell Transcriptome Analysis. Genes (Basel) 2024, 15 PMID: 39766863, DOI: 10.3390/genes15121596.
Intracellular endothelial cell metabolism in vascular function and dysfunctionCitrin K, Chaube B, Fernández-Hernando C, Suárez Y. Intracellular endothelial cell metabolism in vascular function and dysfunction. Trends In Endocrinology And Metabolism 2024 PMID: 39672762, DOI: 10.1016/j.tem.2024.11.004.
Mismatch Repair Proficient Colorectal Adenocarcinoma in Two Patients With Lynch SyndromeKhandakar B, Lacy J, Gibson J. Mismatch Repair Proficient Colorectal Adenocarcinoma in Two Patients With Lynch Syndrome. Clinical Genetics 2024 PMID: 39660603, DOI: 10.1111/cge.14670.
Continuous collective analysis of chemical reactionsHu M, Yang L, Twarog N, Ochoada J, Li Y, Vrettos E, Torres-Hernandez A, Martinez J, Bhatia J, Young B, Price J, McGowan K, Nguyen T, Shi Z, Anyanwu M, Rimmer M, Mercer S, Rankovic Z, Shelat A, Blair D. Continuous collective analysis of chemical reactions. Nature 2024, 636: 374-379. PMID: 39663496, DOI: 10.1038/s41586-024-08211-4.
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastomaMcCord M, Sears T, Wang W, Chaliparambil R, An S, Sarkaria J, James C, Ruggeri B, Gueble S, Bindra R, Horbinski C. The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma. Neuro-Oncology 2024, noae257. PMID: 39658092, DOI: 10.1093/neuonc/noae257.
Integrative spatial protein profiling with multi-omicsFan R. Integrative spatial protein profiling with multi-omics. Nature Methods 2024, 21: 2223-2225. PMID: 39643677, DOI: 10.1038/s41592-024-02533-x.
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney diseaseSrivastava S, Zhou H, Shenoi R, Morris M, Lainez-Mas B, Goedeke L, Rajendran B, Setia O, Aryal B, Kanasaki K, Koya D, Inoki K, Dardik A, Bell T, Fernández-Hernando C, Shulman G, Goodwin J. Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease. Science Advances 2024, 10: eadn6068. PMID: 39630889, PMCID: PMC11616692, DOI: 10.1126/sciadv.adn6068.
Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patencyPark J, Riaz M, Qin L, Zhang W, Batty L, Fooladi S, Kural M, Li X, Luo H, Xu Z, Wang J, Banno K, Gu S, Yuan Y, Anderson C, Ellis M, Zhou J, Luo J, Shi X, Shin J, Liu Y, Lee S, Yoder M, Elder R, Mak M, Thorn S, Sinusas A, Gruber P, Hwa J, Tellides G, Niklason L, Qyang Y. Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency. Cell Stem Cell 2024 PMID: 39644899, DOI: 10.1016/j.stem.2024.11.006.
Predictors of Post-Hepatectomy Liver Failure in Klatskin Tumors: The Role of Preoperative Glucose, Future Liver Remnant to Spleen Ratio, and Early Bilirubin MonitoringKim S, Ku H, Moon H, Song S, Choi Y, Shin D, Koh Y, Oh N, Rhu J, Lee G, Yang W, Song J, Kang C, Ku S, Choi A. Predictors of Post-Hepatectomy Liver Failure in Klatskin Tumors: The Role of Preoperative Glucose, Future Liver Remnant to Spleen Ratio, and Early Bilirubin Monitoring. Diagnostics 2024, 14: 2716. PMID: 39682624, PMCID: PMC11640423, DOI: 10.3390/diagnostics14232716.
Validation of the Delphi Consensus Diagnostic Criteria for Necrobiotic XanthogranulomaBassir F, Valido K, Maciejewski K, Damsky W, Nelson C. Validation of the Delphi Consensus Diagnostic Criteria for Necrobiotic Xanthogranuloma. JAMA Dermatology 2024, 160: 1361-1362. PMID: 39356540, PMCID: PMC11447626, DOI: 10.1001/jamadermatol.2024.3198.
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myelomaDutta R, Thibaud S, Leshchenko V, Ram M, Melnekoff D, Bhalla S, Restrepo P, Gupta V, Barwick B, Newman S, McCafferty J, Hantash F, Nooka A, Cho H, Richard S, Rodriguez C, Rossi A, Sanchez L, Chari A, Boise L, Jagannath S, Richter J, Parekh S, Laganà A. Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma. Blood Neoplasia 2024, 1: 100049. DOI: 10.1016/j.bneo.2024.100049.
215P Differential spatial gene expression and clinicopathologic characteristics are associated with exceptional response to immune checkpoint inhibition in recurrent/metastatic head and neck cancerGavrielatou N, Spathis A, Anastasiou M, Economopoulou P, Foukas G, Lelegiannis I, Aung T, Kotsantis I, Vagia E, Panayiotides I, Rimm D, Foukas P, Psyrri A. 215P Differential spatial gene expression and clinicopathologic characteristics are associated with exceptional response to immune checkpoint inhibition in recurrent/metastatic head and neck cancer. Immuno-Oncology Technology 2024, 24: 100968. DOI: 10.1016/j.iotech.2024.100968.
Uterine teratoma and the role of short-tandem repeat genotyping in understanding originsAlAshqar A, Maruthi V, Abi-Raad R, Greenman M, Hui P, Ratner E, Altwerger G, Santin A, Andikyan V. Uterine teratoma and the role of short-tandem repeat genotyping in understanding origins. Gynecologic Oncology Reports 2024, 56: 101652. PMID: 39698441, PMCID: PMC11652878, DOI: 10.1016/j.gore.2024.101652.
Ezrin drives adaptation of monocytes to the inflamed lung microenvironmentGudneppanavar R, Di Pietro C, H Öz H, Zhang P, Cheng E, Huang P, Tebaldi T, Biancon G, Halene S, Hoppe A, Kim C, Gonzalez A, Krause D, Egan M, Gupta N, Murray T, Bruscia E. Ezrin drives adaptation of monocytes to the inflamed lung microenvironment. Cell Death & Disease 2024, 15: 864. PMID: 39613751, PMCID: PMC11607083, DOI: 10.1038/s41419-024-07255-8.
Complete genome sequence of Vibrio diabolicus bacteriophage vB_Vc_SrVc2 and its efficacy as prophylactic phage therapy.Lomelí-Ortega CO, Barajas-Sandoval D, Ramírez-Sánchez I, Martínez-Villalobos JM, Leptihn S, Quiroz-Guzmán E. Complete genome sequence of Vibrio diabolicus bacteriophage vB_Vc_SrVc2 and its efficacy as prophylactic phage therapy. Virology 2024, 602: 110322. PMID: 39616702, DOI: 10.1016/j.virol.2024.110322.
VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the DiagnosisKo C, Odell I, Gehlhausen J, Leventhal J, McNiff J, Zubek A. VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the Diagnosis. Journal Of Cutaneous Pathology 2024 PMID: 39610062, DOI: 10.1111/cup.14757.
Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanomaLu B, Lucca L, Lewis W, Wang J, Nogueira C, Heer S, Rayon-Estrada V, Axisa P, Reeves S, Buitrago-Pocasangre N, Pham G, Kojima M, Wei W, Aizenbud L, Bacchiocchi A, Zhang L, Walewski J, Chiang V, Olino K, Clune J, Halaban R, Kluger Y, Coyle A, Kisielow J, Obermair F, Kluger H, Hafler D. Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma. Nature Immunology 2024, 26: 82-91. PMID: 39609626, DOI: 10.1038/s41590-024-02023-4.
Isolation and characterization of Salmonella enterica- and Escherichia coli-specific bacteriophages of the genus Epseptimavirus from wastewater in Minnesota.Cortes-Ortega E, Hansen EG, Iskender I, Farmer ML, Martinez-Villalobos JM, Vitt JD, Bowden SD. Isolation and characterization of Salmonella enterica- and Escherichia coli-specific bacteriophages of the genus Epseptimavirus from wastewater in Minnesota. Arch Virol 2024, 169: 255. PMID: 39601978, DOI: 10.1007/s00705-024-06190-5.
Presence of Mood and/or Anxiety Disorders Does Not Affect Success of Weight Management Therapies in Metabolic Dysfunction-Associated Steatotic Liver DiseaseBollinger B, Cotter R, Deng Y, Ilagan-Ying Y, Gupta V. Presence of Mood and/or Anxiety Disorders Does Not Affect Success of Weight Management Therapies in Metabolic Dysfunction-Associated Steatotic Liver Disease. Digestive Diseases And Sciences 2024, 1-8. PMID: 39604664, DOI: 10.1007/s10620-024-08724-y.
Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohortJaber Chehayeb R, Singh J, Matute-Martinez C, Chen N, Guajardo A, Lin D, Jayakrishnan R, Christofides A, Leveille E, Im Y, Biancon G, VanOudenhove J, Ibrahim E, Ardasheva A, Jha A, Hwa J, Halene S, Kwan J. Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort. Cardio-Oncology 2024, 10: 84. PMID: 39587635, PMCID: PMC11590368, DOI: 10.1186/s40959-024-00289-z.
Setdb1-loss induces type-I interferons and immune clearance of melanoma.McGeary M, Damsky W, Daniels A, Lang S, Xu Q, Song E, Huet-Calderwood C, Lou H, Paradkar S, Micevic G, Kaech S, Calderwood D, Turk B, Yan Q, Iwasaki A, Bosenberg M. Setdb1-loss induces type-I interferons and immune clearance of melanoma. Cancer Immunology Research 2024 PMID: 39589394, DOI: 10.1158/2326-6066.cir-23-0514.
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancerRobles-Oteíza C, Hastings K, Choi J, Sirois I, Ravi A, Expósito F, de Miguel F, Knight J, López-Giráldez F, Choi H, Socci N, Merghoub T, Awad M, Getz G, Gainor J, Hellmann M, Caron É, Kaech S, Politi K. Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer. Journal Of Experimental Medicine 2024, 222: e20231106. PMID: 39585348, PMCID: PMC11602551, DOI: 10.1084/jem.20231106.
CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cellsPellegrino B, David K, Rabani S, Lampert B, Tran T, Doherty E, Piecychna M, Meza-Romero R, Leng L, Hershkovitz D, Vandenbark A, Bucala R, Becker-Herman S, Shachar I. CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells. PLOS Biology 2024, 22: e3002905. PMID: 39576827, PMCID: PMC11623796, DOI: 10.1371/journal.pbio.3002905.
Host Immune Response to Dengue Virus Infection: Friend or Foe?Priya Dhole*^, Amir Zaidi*, H.K. Nariya, Shruti Sinha, Sandhya Jinesh, Shivani Srivastava^. Host Immune Response to Dengue Virus Infection: Friend or Foe? Immuno. 2024; 4(4):549-577.
UBXN9 governs GLUT4-mediated spatial confinement of RIG-I-like receptors and signalingHarrison A, Yang D, Cahoon J, Geng T, Cao Z, Karginov T, Hu Y, Li X, Chiari C, Qyang Y, Vella A, Fan Z, Vanaja S, Rathinam V, Witczak C, Bogan J, Wang P. UBXN9 governs GLUT4-mediated spatial confinement of RIG-I-like receptors and signaling. Nature Immunology 2024, 25: 2234-2246. PMID: 39567760, DOI: 10.1038/s41590-024-02004-7.
Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinomaSchoenfeld D, Djureinovic D, Su D, Zhang L, Lu B, Kamga L, Mann J, Huck J, Hurwitz M, Braun D, Jilaveanu L, Ring A, Kluger H. Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma. JCI Insight 2024 PMID: 39561007, DOI: 10.1172/jci.insight.184545.
Proteomic and phosphoproteomic identified structural and functional changes in the aorta associate with age-dependent hypertension in male Sprague Dawley ratsAmraei R, Lampl N, Nist K, Zhang Y, Wainford R. Proteomic and phosphoproteomic identified structural and functional changes in the aorta associate with age-dependent hypertension in male Sprague Dawley rats. Physiological Genomics 2024 PMID: 39548828, DOI: 10.1152/physiolgenomics.00052.2024.
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?Vidal J, Tsiknakis N, Staaf J, Bosch A, Ehinger A, Nimeus E, Salgado R, Bai Y, Rimm D, Hartman J, Acs B. The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably? EClinicalMedicine 2024, 78: 102928. PMID: 39634035, PMCID: PMC11615110, DOI: 10.1016/j.eclinm.2024.102928.
Cognitive Bias: Chromoblastomycosis misdiagnosed as a giant cell tumor of soft tissue in a kidney transplant recipientWang S, Cowper S, Ko C. Cognitive Bias: Chromoblastomycosis misdiagnosed as a giant cell tumor of soft tissue in a kidney transplant recipient. Journal Of The American Academy Of Dermatology 2024 PMID: 39549847, DOI: 10.1016/j.jaad.2024.10.087.
Scavenger Receptor CD36 in Tumor-Associated Macrophages Promotes Cancer Progression by Dampening Type I Interferon Signaling.Xu Z, Kuhlmann-Hogan A, Xu S, Tseng H, Chen D, Tan S, Sun M, Tripple V, Bosenberg M, Miller-Jensen K, Kaech S. Scavenger Receptor CD36 in Tumor-Associated Macrophages Promotes Cancer Progression by Dampening Type I Interferon Signaling. Cancer Research 2024 PMID: 39546763, DOI: 10.1158/0008-5472.can-23-4027.
Abstract B029: Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correctionLi X, Liu T, Bacchiocchi A, Li M, Cheng W, Wittkop T, Mendez F, Wang Y, Tang P, Yeung G, Yao Q, Bosenberg M, Sznol M, Yan Q, Faham M, Weng L, Halaban R, Jin H, Hu Z. Abstract B029: Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction. Clinical Cancer Research 2024, 30: b029-b029. DOI: 10.1158/1557-3265.liqbiop24-b029.
Abstract 4141772: “SETDB2 regulates the Innate Immune Memory response and influences Inflammatory Immune landscape in Atherosclerosis”JAISWAL A, Halasz L, Suarez Y, Fernandez-Hernando C, Osborne T. Abstract 4141772: “SETDB2 regulates the Innate Immune Memory response and influences Inflammatory Immune landscape in Atherosclerosis”. Circulation 2024, 150: a4141772-a4141772. DOI: 10.1161/circ.150.suppl_1.4141772.
Abstract 4144255: Treatment of Human Engineered Heart Tissue with Serum from Cancer Patients with Clonal Hematopoiesis of Indeterminate Potential Cytokine Leads to Impaired FunctionKaur H, Halder S, Espinoza J, Chen N, VanOudenhove J, Biancon G, Gu S, Chakraborty R, Jain K, Park J, Qyang Y, Ibrahim E, Halene S, Hwa J, Campbell S, Jha A, Kwan J. Abstract 4144255: Treatment of Human Engineered Heart Tissue with Serum from Cancer Patients with Clonal Hematopoiesis of Indeterminate Potential Cytokine Leads to Impaired Function. Circulation 2024, 150: a4144255-a4144255. DOI: 10.1161/circ.150.suppl_1.4144255.
Advanced Glycosylation EndproductsBucala R, Vlassara H, Cerami A. Advanced Glycosylation Endproducts. 2024, 53-79. DOI: 10.1201/9781003574163-2.
Forensic Pathologist Testimony, Part 2: Special Issues and Considerations.Ely S, Gill J. Forensic Pathologist Testimony, Part 2: Special Issues and Considerations. Academic Forensic Pathology 2024, 19253621241297295. PMID: 39544452, PMCID: PMC11558645, DOI: 10.1177/19253621241297295.
Forensic Pathologist Testimony, Part 1: Common Questions and Considerations.Gill J, Ely S. Forensic Pathologist Testimony, Part 1: Common Questions and Considerations. Academic Forensic Pathology 2024, 19253621241297350. PMID: 39544453, PMCID: PMC11558648, DOI: 10.1177/19253621241297350.
EPCO-35. GENOMIC CHARACTERIZATION OF GROWTH HORMONE SECRETING PITUITARY ADENOMASAlanya H, Yalcin K, Hilton B, Gultekin B, Mishra-Gorur K, McGuone D, Gunel M, Omay S, Erson-Omay Z. EPCO-35. GENOMIC CHARACTERIZATION OF GROWTH HORMONE SECRETING PITUITARY ADENOMAS. Neuro-Oncology 2024, 26: viii9-viii9. PMCID: PMC11553213, DOI: 10.1093/neuonc/noae165.0034.
EXTH-23. NEW DNA-CROSSLINKING CHEMOTHERAPY IS EFFECTIVE AGAINST POST-TEMOZOLOMIDE MISMATCH REPAIR-DEFICIENT PATIENT-DERIVED HYPERMUTANT GLIOMASMcCord M, Wang W, An S, Sears T, Sarkaria J, James C, Ruggieri B, Bindra R, Horbinski C. EXTH-23. NEW DNA-CROSSLINKING CHEMOTHERAPY IS EFFECTIVE AGAINST POST-TEMOZOLOMIDE MISMATCH REPAIR-DEFICIENT PATIENT-DERIVED HYPERMUTANT GLIOMAS. Neuro-Oncology 2024, 26: viii241-viii241. PMCID: PMC11553709, DOI: 10.1093/neuonc/noae165.0954.
R-Spondin 1 Suppresses Inflammatory Cytokine Production in Human Cortical AstrocytesLogan R, Bhatta S, Sutova H, Hafler B, Miller S. R-Spondin 1 Suppresses Inflammatory Cytokine Production in Human Cortical Astrocytes. Neuroglia 2024, 5: 445-451. DOI: 10.3390/neuroglia5040028.
Exploiting blood-based biomarkers to align preclinical models with human traumatic brain injuryLisi I, Moro F, Mazzone E, Marklund N, Pischiutta F, Kobeissy F, Mao X, Corrigan F, Helmy A, Nasrallah F, Di Pietro V, Ngwenya L, Portela L, Semple B, Schneider A, Diaz Arrastia R, Menon D, Smith D, Wellington C, Loane D, Wang K, Zanier E, Abbasloo E, Agrawal A, Anwer M, Anyaegbu C, Caeyenberghs K, Collins L, Corrigan F, Cowen G, Portela L, Cullen J, D'Alonzo B, Di Pietro V, Keene C, Esser M, Giersztein S, Helmy A, Hoffman S, Iacono D, Jha R, Johnson V, Justus J, Keene C, Lins B, Liebel S, Loane D, Mao X, Marklund N, McCrea M, McGuone D, Mohamed A, Moro F, Mychasiuk R, Nagarajan G, Nasrallah F, Ngum P, Ngwenya L, Oteng R, Parihar A, Phillips J, Pischiutta F, Prakash S, Robba C, Rostami E, Roselli F, Semple B, Shultz S, Smith D, Song H, Stefani M, Stewart W, Verma R, Wang K, Wellington C, Winston B, Zanier E. Exploiting blood-based biomarkers to align preclinical models with human traumatic brain injury. Brain 2024, awae350. PMID: 39514789, DOI: 10.1093/brain/awae350.
Adamts1 and Cyst Expansion in Polycystic Kidney Disease.Kakade V, Akman Z, Motrapu M, Cassini M, Xu L, Moeckel G, Somlo S, Cantley L. Adamts1 and Cyst Expansion in Polycystic Kidney Disease. Journal Of The American Society Of Nephrology 2024 PMID: 39514301, DOI: 10.1681/asn.0000000557.
GPR68 supports AML cells through the calcium/calcineurin pro-survival pathway and confers chemoresistance by mediating glucose metabolic symbiosisHe X, Hawkins C, Lawley L, Phan T, Park I, Joven N, Zhang J, Wunderlich M, Mizukawa B, Pei S, Patel A, VanOudenhove J, Halene S, Fang J. GPR68 supports AML cells through the calcium/calcineurin pro-survival pathway and confers chemoresistance by mediating glucose metabolic symbiosis. Biochimica Et Biophysica Acta (BBA) - Molecular Basis Of Disease 2024, 1871: 167565. PMID: 39522891, DOI: 10.1016/j.bbadis.2024.167565.
712 Modeling response to alkylating chemotherapy in a syngeneic model of MMR-deficient gliomaBhatt D, Sundaram R, López K, Friedman S, Gueble S, Bindra R, Vasquez J. 712 Modeling response to alkylating chemotherapy in a syngeneic model of MMR-deficient glioma. 2024, a814-a814. DOI: 10.1136/jitc-2024-sitc2024.0712.
109 Development of a novel immuno-metabolic spatial signature to predict response and resistance to immunotherapy in NSCLC patientsMarkovits E, Monkman J, Aung T, Reeves J, O’Byrne K, Czertock R, Puig O, Rimm D, Kulasinghe A. 109 Development of a novel immuno-metabolic spatial signature to predict response and resistance to immunotherapy in NSCLC patients. 2024, a119-a119. DOI: 10.1136/jitc-2024-sitc2024.0109.
127 Digital pathology prognostic biomarkers- time for clinical application in melanomaSaenger Y, Zhang C, Espinoza G, Bracero Y, Kenchappa D, Moon J, Matteo A, Bioh L, Sultana S, Singh A, Aung T, Gartrell R, Leung L, Ferringer T, Chang R, Horst B, Nastiuk K, Rimm D, Geskin L. 127 Digital pathology prognostic biomarkers- time for clinical application in melanoma. 2024, a140-a141. DOI: 10.1136/jitc-2024-sitc2024.0127.
582 Spatial profiling reveals architecture difference between primary and lung metastatic ccRCCWang Y, Cho J, Laimon Y, Sheshdeh A, Murugan N, Yuan H, Wee J, Xu W, Braun D, Choueiri T, Wu C, Signoretti S, Freeman G, Hemberg M, Marasco W. 582 Spatial profiling reveals architecture difference between primary and lung metastatic ccRCC. 2024, a662-a662. DOI: 10.1136/jitc-2024-sitc2024.0582.
MISTRG6kitW41: Enhanced Engraftment in a Cytokine Humanized Patient-Derived Xenotransplantation Mouse ModelBaassiri A, Maziarz J, Blackburn H, Maul-Newby H, VanOudenhove J, Zhang X, Matthews M, Paul S, Liu W, Sefik E, Salomonis N, Grimes H, Flavell R, Halene S. MISTRG6kitW41: Enhanced Engraftment in a Cytokine Humanized Patient-Derived Xenotransplantation Mouse Model. Blood 2024, 144: 1815-1815. DOI: 10.1182/blood-2024-211908.
Immune Landscape and Outcomes of Patients with RNA Splicing Factor-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes Treated with Azacitidine +/- the Anti-PD-L1 Antibody DurvalumabBewersdorf J, Hasle V, Shallis R, Thompson E, De Menezes D, Rose S, Boss I, Mendez L, Podoltsev N, Stahl M, Kewan T, Halene S, Haferlach T, Fox B, Zeidan A. Immune Landscape and Outcomes of Patients with RNA Splicing Factor-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes Treated with Azacitidine +/- the Anti-PD-L1 Antibody Durvalumab. Blood 2024, 144: 4585. DOI: 10.1182/blood-2024-194929.
Serum Free Light Chain Ratio Is Inversely Proportional to the Egfr, and Has Been Increasing over the Last DecadeNajarro G, Gupta V, Joseph N, Kaufman J, Nooka A, Dhodapkar M, Lonial S, Hofmeister C. Serum Free Light Chain Ratio Is Inversely Proportional to the Egfr, and Has Been Increasing over the Last Decade. Blood 2024, 144: 5142-5142. DOI: 10.1182/blood-2024-202078.
Survival of Multiple Myeloma Patients in Epic Cosmos Confounded By Death ReportingHofmeister C, Zhang M, Gupta V, Joseph N, Kaufman J, Nooka A, Dhodapkar M, Lonial S, Sborov D. Survival of Multiple Myeloma Patients in Epic Cosmos Confounded By Death Reporting. Blood 2024, 144: 5152-5152. DOI: 10.1182/blood-2024-202100.
A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple MyelomaHofmeister C, Gupta V, Kaufman J, Nooka A, Joseph N, Lonial S, Dhodapkar M. A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma. Blood 2024, 144: 255-255. DOI: 10.1182/blood-2024-202102.
A Slow-Go Treatment in Newly Diagnosed AL Amyloidosis with Severe CardiomyopathyHofmeister C, Gupta V, Joseph N, Lonial S, Dhodapkar M, Nooka A, Kaufman J. A Slow-Go Treatment in Newly Diagnosed AL Amyloidosis with Severe Cardiomyopathy. Blood 2024, 144: 4672. DOI: 10.1182/blood-2024-203485.
Genomic Determinants of Clinical Outcomes in Multiple Myeloma with t(11;14)(CCND1;IGH) Treated with VenetoclaxKaddoura M, Wiedmeier-Nutor J, Gupta V, Ziccheddu B, Shivaram S, Tang H, Fonseca R, Durante M, Matulis S, Jelinek T, Landgren O, Mitsiades C, Bergsagel P, Braggio E, Boise L, Fonseca R, Kumar S, Maura F, Baughn L. Genomic Determinants of Clinical Outcomes in Multiple Myeloma with t(11;14)(CCND1;IGH) Treated with Venetoclax. Blood 2024, 144: 249. DOI: 10.1182/blood-2024-204071.
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at Two InstitutesVarga C, Robinson M, Gupta V, Hofmeister C, Nooka A, Kaufman J, Dhodapkar M, Lonial S, Borden S, Ferreri C, Paul B, Atrash S, Bhutani M, Voorhees P, Joseph N. Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at Two Institutes. Blood 2024, 144: 4702-4702. DOI: 10.1182/blood-2024-204388.
The Role of NOXA in Venetoclax Treatment Response in Multiple MyelomaShivaram S, Yan H, Tang H, Anderson H, Kaddoura M, Wiedmeier-Nutor J, Tian S, Howe M, Bolarinwa A, Zepeda Mendoza C, Gupta V, Lehman S, Mitsiades C, Bergsagel P, Braggio E, Boise L, Fonseca R, Maura F, Kumar S, Baughn L. The Role of NOXA in Venetoclax Treatment Response in Multiple Myeloma. Blood 2024, 144: 4635-4635. DOI: 10.1182/blood-2024-205385.
Risk of Infections in Multiple Myeloma Patients Treated with Bispecific AntibodiesCani L, Scott S, Joseph N, Hofmeister C, Gupta V, Dhodapkar M, Lonial S, Nooka A, Kaufman J. Risk of Infections in Multiple Myeloma Patients Treated with Bispecific Antibodies. Blood 2024, 144: 3311. DOI: 10.1182/blood-2024-206155.
Iberdomide Alone or in Combination with Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma (SMM)Joseph N, Kaufman J, Hofmeister C, Gupta V, Burton B, Pruitt R, Nooka A, Dhodapkar M, Lonial S. Iberdomide Alone or in Combination with Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma (SMM). Blood 2024, 144: 1983-1983. DOI: 10.1182/blood-2024-210335.
Mitochondrial Priming Is Heterogenous in t(4;14) Multiple Myeloma and Can be Induced By Inhibition of NSD2Matulis S, Chavez R, Owens R, Wiita A, Shanmugam M, De Matos Simoes R, Mitsiades C, Joseph N, Hofmeister C, Kaufman J, Dhodapkar M, Lonial S, Nooka A, Gupta V, Licht J, Barwick B, Boise L. Mitochondrial Priming Is Heterogenous in t(4;14) Multiple Myeloma and Can be Induced By Inhibition of NSD2. Blood 2024, 144: 4663-4663. DOI: 10.1182/blood-2024-210441.
Single Center Institutional Experience and Outcomes Administering Both Anti-BCMA and Anti-GPRC5D Bispecific T-Cell EngagersAllada S, Gupta V, Hofmeister C, Kaufman J, Dhodapkar M, Lonial S, Nooka A, Joseph N. Single Center Institutional Experience and Outcomes Administering Both Anti-BCMA and Anti-GPRC5D Bispecific T-Cell Engagers. Blood 2024, 144: 7861. DOI: 10.1182/blood-2024-210996.
Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with Early Progression Following Induction with Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVd)Gu L, Joseph N, Gupta V, Hofmeister C, Dhodapkar M, Lonial S, Nooka A, Kaufman J. Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with Early Progression Following Induction with Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVd). Blood 2024, 144: 3780. DOI: 10.1182/blood-2024-211474.
Impact of Self-Identified Race on Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients Receiving Induction Therapy with Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVd)Joseph N, Gupta S, Kaufman J, Dicamillo S, Roberts D, Gupta V, Hofmeister C, Dhodapkar M, Lonial S, Nooka A. Impact of Self-Identified Race on Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients Receiving Induction Therapy with Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVd). Blood 2024, 144: 7870-7870. DOI: 10.1182/blood-2024-211988.
Gene Copy Number Alterations Identify Subsets of Mycosis Fungoides/Sézary Syndrome Patients with Worse Survival OutcomesKiwan A, Kewan T, Xu M, Siddon A, Girardi M, Sethi T, Foss F. Gene Copy Number Alterations Identify Subsets of Mycosis Fungoides/Sézary Syndrome Patients with Worse Survival Outcomes. Blood 2024, 144: 4440-4440. DOI: 10.1182/blood-2024-205144.
Clinically Driven Algorithms Identify Patients with Large Granular Lymphocytic Leukemia at Risk of Significant Cytopenia Requiring TreatmentKiwan A, Kewan T, Bravo-Perez C, Visconte V, Gurnari C, Durmaz A, Siddon A, Halene S, Sethi T, Maciejewski J, Foss F. Clinically Driven Algorithms Identify Patients with Large Granular Lymphocytic Leukemia at Risk of Significant Cytopenia Requiring Treatment. Blood 2024, 144: 4436. DOI: 10.1182/blood-2024-209344.
Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH InhibitorsGoldberg L, Yoon J, Johnston H, Davidson M, Siddon A, Shallis R, Chen E, Burkart M, Oh T, Iyer S, Madarang E, Muthiah C, Kassner J, Rampal R, Guru Murthy G, Bradley T, Abaza Y, Garcia J, Gupta V, Pettit K, Odenike O, Cursio J, Patel A. Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH Inhibitors. Blood 2024, 144: 1787-1787. DOI: 10.1182/blood-2024-197898.
Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective StudyCohen-Nowak A, Coltoff A, Patel A, Atallah E, El Kettani M, Wang J, Symes E, Venkataraman G, Siddon A, Giever E, Shallis R, Altman J, Bell-Burdett K, Badar T, Aqil B, Abaza Y. Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective Study. Blood 2024, 144: 2801-2801. DOI: 10.1182/blood-2024-199377.
Impact of Sepsis and Stress Hematopoiesis on the Acquisition and Persistence of Clonal HematopoiesisOgbue O, Kewan T, Unlu S, Lakhotiya K, Mehkri O, Ellison R, Fadell F, Reynolds M, Cheema A, Durmaz A, Brady Z, VanOudenhove J, Singh A, Visconte V, Mendez L, Bosler D, Duggal A, Halene S, Al-Jaghbeer M, Maciejewski J, Gurnari C. Impact of Sepsis and Stress Hematopoiesis on the Acquisition and Persistence of Clonal Hematopoiesis. Blood 2024, 144: 5634-5634. DOI: 10.1182/blood-2024-209240.
O6-Guanine Targeting Novel DNA Cross-Linker and ATR Inhibitor Combination for MGMT-Silenced IDH1/2 Mutant Acute Myeloid LeukemiaBhardwaj P, Sundaram R, Friedman S, Baassiri A, Matthews M, VanOudenhove J, Gueble S, Halene S, Bindra R. O6-Guanine Targeting Novel DNA Cross-Linker and ATR Inhibitor Combination for MGMT-Silenced IDH1/2 Mutant Acute Myeloid Leukemia. Blood 2024, 144: 6130. DOI: 10.1182/blood-2024-210621.
Clonal Dissection of MDS and Secondary AML Resolves Shared Splicing Neoantigens and Mechanistic Underpinnings of Hypomethylating Agent Therapeutic ResponseZhang X, Li G, Oliverio A, VanOudenhove J, DeZern A, Ghiaur G, Halene S, Grimes H, Salomonis N. Clonal Dissection of MDS and Secondary AML Resolves Shared Splicing Neoantigens and Mechanistic Underpinnings of Hypomethylating Agent Therapeutic Response. Blood 2024, 144: 1810-1810. DOI: 10.1182/blood-2024-211099.
Unraveling the Drivers of the Stress Granule Signature in Splicing Factor-Mutant Myeloid MalignanciesBiancon G, Busarello E, Cheng M, Sidoli S, VanOudenhove J, Bucciarelli G, Tebaldi T, Halene S. Unraveling the Drivers of the Stress Granule Signature in Splicing Factor-Mutant Myeloid Malignancies. Blood 2024, 144: 4117. DOI: 10.1182/blood-2024-211265.
Mouse Models of Hereditary Xerocytosis-Associated PIEZO1 Mutations Reveal Genotype-Phenotype Differences in Hematological Defects and Iron LoadingFinberg K, Peres Diaz L, Shan P, Chua E, Lalwani K, Gallagher P. Mouse Models of Hereditary Xerocytosis-Associated PIEZO1 Mutations Reveal Genotype-Phenotype Differences in Hematological Defects and Iron Loading. Blood 2024, 144: 3851-3851. DOI: 10.1182/blood-2024-203740.
Randomized phase II trial of weekly ixabepilone with or without biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer: Updated survival and subgroup analysesRoque D, Siegel E, Buza N, Bellone S, Huang G, Andikyan V, Clark M, Azodi M, Schwartz P, Rao G, Xu F, Hui P, Altwerger G, Ratner E, Santin A. Randomized phase II trial of weekly ixabepilone with or without biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer: Updated survival and subgroup analyses. Gynecologic Oncology 2024, 190: s299-s301. DOI: 10.1016/j.ygyno.2024.07.449.
Cutaneous fungal infections in the United States: A cross-sectional analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 2005–2016Spaulding S, Wride A, Slade M, Damsky W, Cohen J. Cutaneous fungal infections in the United States: A cross-sectional analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 2005–2016. Journal Of The American Academy Of Dermatology 2024 PMID: 39486764, DOI: 10.1016/j.jaad.2024.10.035.
Correction of Paradoxical Mineralization in Murine CKD-MBD by ENPP1 Enzyme Biologics: SA-PO252.Hajime Kato, Hana Kim, Tayyaba Ishaq, Dominique Sims, Shivani Srivastava, Paul Stabach, Thomas O. Carpenter, W.Charles O’ Neill, Demetrios T. Braddock. Correction of Paradoxical Mineralization in Murine CKD-MBD by ENPP1 Enzyme Biologics: SA-PO252. Journal of the American Society of Nephrology. 35(10S)-October 2024. DOI: 10.1681/ASN.2024sre0cym1. (Poster)
Introduction and General Consideration of Radiology-Pathology CorrelationHarigopal M, Andrejeva L, Podany P, Lewin J, Raghu M, Singh K. Introduction and General Consideration of Radiology-Pathology Correlation. 2024, 1-9. DOI: 10.1007/978-3-031-65711-5_1.
Complex Cystic and Solid MassesHarigopal M, Cole K, Podany P, Verma A, Andrejeva L. Complex Cystic and Solid Masses. 2024, 57-95. DOI: 10.1007/978-3-031-65711-5_3.
Circumscribed MassesHarigopal M, Raghu M, Pham R, Rende A, Podany P, Andrejeva L. Circumscribed Masses. 2024, 11-55. DOI: 10.1007/978-3-031-65711-5_2.
Discordances Between Radiology and PathologyHarigopal M, Verma A, Andrejeva L, Lewin J. Discordances Between Radiology and Pathology. 2024, 375-391. DOI: 10.1007/978-3-031-65711-5_14.
Spiculated MassesHarigopal M, Andrejeva L, Lanjewar S, Podany P. Spiculated Masses. 2024, 127-158. DOI: 10.1007/978-3-031-65711-5_5.
Rare Breast TumorsHarigopal M, Podany P, Andrejeva L, Singh K. Rare Breast Tumors. 2024, 343-374. DOI: 10.1007/978-3-031-65711-5_13.
Architectural DistortionsButler R, Durand M, Lanjevar S, Podany P, Andrejeva L, Harigopal M. Architectural Distortions. 2024, 185-207. DOI: 10.1007/978-3-031-65711-5_7.
Masses with Indistinct MarginsSingh K, Lee J, Harigopal M, Andrejeva L. Masses with Indistinct Margins. 2024, 97-125. DOI: 10.1007/978-3-031-65711-5_4.
Skin Thickening and Vascular LesionsAndrejeva L, Lanjewar S, Woolf G, Killelea B, Brownson K, Podany P, Harigopal M. Skin Thickening and Vascular Lesions. 2024, 297-323. DOI: 10.1007/978-3-031-65711-5_11.
Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brainsZhu B, Park J, Coffey S, Russo A, Hsu I, Wang J, Su C, Chang R, Lam T, Gopal P, Ginsberg S, Zhao H, Hafler D, Chandra S, Zhang L. Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brains. Science Translational Medicine 2024, 16: eabo1997. PMID: 39475571, DOI: 10.1126/scitranslmed.abo1997.
The effect of adrenalectomy on bleomycin-induced pulmonary fibrosis in miceMcGovern J, Perry C, Ghincea A, Herzog E, Shao S, Sun H. The effect of adrenalectomy on bleomycin-induced pulmonary fibrosis in mice. American Journal Of Physiology - Lung Cellular And Molecular Physiology 2024, 328: l15-l29. PMID: 39470613, DOI: 10.1152/ajplung.00062.2024.
Effects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic responseLin Y, Xie M, Lau H, Zeng R, Zhang R, Wang L, Li Q, Wang Y, Chen D, Jiang L, Damsky W, Yu J. Effects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic response. Med 2024 PMID: 39515321, DOI: 10.1016/j.medj.2024.10.007.
Sex differences in proteomics of cardiovascular disease: results from the Yale-CMD registryLiu Y, Wang Z, Collins S, Testani J, Kleinstein S, Safdar B. Sex differences in proteomics of cardiovascular disease: results from the Yale-CMD registry. European Heart Journal 2024, 45: ehae666.3091. DOI: 10.1093/eurheartj/ehae666.3091.
Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or ExpressionDarbinian N, Merabova N, Tatevosian G, Adele S, Darbinyan A, Morrison M, DeVane C, Ramamoorthy S, Goetzl L, Selzer M. Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression. International Journal Of Molecular Sciences 2024, 25: 11570. PMID: 39519122, PMCID: PMC11546934, DOI: 10.3390/ijms252111570.
CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitorsKwon N, Lu Y, Thompson E, Mancuso R, Wang L, Zhang P, Krause D. CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors. Blood 2024, 144: 1800-1812. PMID: 39102635, PMCID: PMC11530366, DOI: 10.1182/blood.2024023963.

Download Full List